While CD45– tumor stroma in C-GBM and NC-GBM expressed a variety of immune checkpoint receptors/ligands, we found no difference in the frequency of checkpoint-positive tumor cells in C-GBM and NC-GBM tumors (Supplemental Figure 10K). The gene discussed is PTPRC; the disease is glioblastoma.